logo

For the Inventor, By the Inventor

Hatboro, PA, United States of America

Gregory P Adams

This inventor holds 11 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignees: Fox Chase Cancer Center, University of California, Elucida Oncology, Inc.. Active years: 2008-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gregory P Adams. Retrieved from https://idiyas.com/inventor/gregory-p-adams

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 

% Patents Active = 36.4

 

Average Co-Inventor Count = 4.7

ph-index = 4

Forward Citations = 127(Granted Patents)


Location History:

  • Philadelphia, PA (US) (2008)
  • Hatboro, PA (US) (2008 - 2024)

Company Filing History:

goldMedal8 out of 81 
 
Fox Chase Cancer Center
 patents
silverMedal5 out of 16,008 
 
University of California
 patents
bronzeMedal2 out of 2 
 
Elucida Oncology, Inc.
 patents
4. 1 out of 69 
 
Institute for Cancer Research
 patents
where one patent can have more than one assignee

Years Active: 2008-2024

Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents
1. 11957760 - Folate receptor targeted nanoparticle drug conjugates and uses thereof (2024-04-16),
2. 11744897 - Folate receptor targeted nanoparticle drug conjugates and uses thereof (2023-09-05),
3. 11261225 - Chimera of bone morphogenic protein 2 and the Müllerian-inhibiting substance type II receptor binding region of Müllerian-inhibiting substance (2022-03-01),
4. 9611321 - Rationally-designed anti-mullerian inhibiting substance type II receptor antibodies (2017-04-04),
5. 8980258 - Bispecific single chain Fv antibody molecules and methods of use therof (2015-03-17),
6. 8580263 - Anti-EGFR family antibodies, bispecific anti-EGFR family antibodies and methods of use thereof (2013-11-12),
7. 8329873 - Bispecific single chain Fv antibody molecules and methods of use thereof (2012-12-11),
8. 8198411 - Anti-mullerian inhibiting substance type II receptor (MISIIR) immunoconjugates to detect and treat cancer (2012-06-12),
9. 7781568 - Anti-mullerian inhibiting substance type II receptor (MISIIR) immunoconjugates to detect and treat cancer (2010-08-24),
10. 7332585 - Bispecific single chain Fv antibody molecules and methods of use thereof (2008-02-19),
11. 7332580 - Bispecific single chain Fv antibody molecules and methods of use thereof (2008-02-19),

Title: The Innovative Journey of Gregory P Adams

Introduction: Gregory P Adams, a talented inventor hailing from Hatboro, PA (US), has made significant contributions to the world of innovations with his creative mind and dedication to problem-solving.

Latest Patents: Gregory P Adams holds several patents in various fields, including technology, healthcare, and consumer products. His most recent patents focus on cutting-edge advancements in renewable energy and sustainable materials.

Career Highlights: With a background in engineering and a passion for creating solutions, Gregory P Adams has had a remarkable career marked by groundbreaking inventions. His work has not only improved existing technologies but has also paved the way for new industries to thrive.

Collaborations: Throughout his career, Gregory P Adams has collaborated with leading research institutions, universities, and innovative companies to bring his ideas to life. His ability to work in multidisciplinary teams has led to the successful development and commercialization of his inventions.

Conclusion: Gregory P Adams stands as a shining example of an inventor whose relentless pursuit of innovation has left a lasting impact on the world. His dedication to pushing the boundaries of what is possible continues to inspire future generations of inventors and innovators.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…